Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07762443
PHASE1

A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD

View on ClinicalTrials.gov

Summary

This study is a multicenter, open-label, non-randomized, dose-finding Phase I study designed to evaluate the pharmacokinetics (PK), safety, and preliminary efficacy of VC005 tablets in adolescent subjects with severe alopecia areata (AA).

Official title: A Phase I Study to Evaluate the Pharmacokinetics, Safety, and Preliminary Efficacy of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata

Key Details

Gender

All

Age Range

12 Years - 18 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2026-09-30

Completion Date

2027-12-30

Last Updated

2026-08-13

Healthy Volunteers

No

Conditions

Interventions

DRUG

VC005 tablets

VC005 repeat administration for 24 weeks

Locations (1)

The Peking University People's Hospital

Beijing, Beijing Municipality, China